The most common subtypes in phase 2 included PTCL-NOS (42.5%), AITL (36.3%), and ALK-negative ALCL [ALK-ALCL (15.0%)]. Here, ALK is linked to mature T-cell and NK-cell non-Hodgkin lymphoma.